Headlines

Novartis weighs deal for biotech Avidity Biosciences, FT reports

Published by Global Banking & Finance Review

Posted on August 6, 2025

1 min read

· Last updated: January 22, 2026

Add as preferred source on Google
Novartis weighs deal for biotech Avidity Biosciences, FT reports
Global Banking & Finance Awards 2026 — Call for Entries

(Corrects typo in paragraph 1) (Reuters) -Swiss drugmaker Novartis has approached U.S. biotech Avidity Biosciences for a potential takeover offer, the Financial Times reported, citing people familiar

Novartis weighs deal for biotech Avidity Biosciences, FT reports

(Corrects typo in paragraph 1)

(Reuters) -Swiss drugmaker Novartis has approached U.S. biotech Avidity Biosciences for a potential takeover offer, the Financial Times reported, citing people familiar with the matter

(Reporting by Padmanabhan Ananthan in Bengaluru; Editing by Arun Koyyur)

Key Takeaways

  • Novartis is exploring a potential takeover of Avidity Biosciences.
  • The Financial Times reported the news citing anonymous sources.
  • This move could expand Novartis's biotech portfolio.
  • The deal is still in the early stages of discussion.
  • No official comment from Novartis or Avidity Biosciences yet.

Frequently Asked Questions

What company is Novartis considering acquiring?
Novartis is considering acquiring U.S. biotech Avidity Biosciences.
Which publication reported on Novartis's potential acquisition?
The Financial Times reported on Novartis's potential acquisition of Avidity Biosciences.
Who reported the news about the Novartis acquisition?
The news was reported by Padmanabhan Ananthan in Bengaluru.

Tags

Related Articles

More from Headlines

Explore more articles in the Headlines category